Yuyu Pharma Inc (000225) — Capital Reinvestment Ratio

Latest as of March 2026: 1.08x

Yuyu Pharma Inc (000225) has a Capital Reinvestment Ratio of 1.08x as of March 2026, meaning it reinvests 1% of its operating cash flow (₩2.95 Billion) in capital expenditures (₩3.19 Billion). Check Yuyu Pharma Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.08x
Capex / Operating Cash Flow

Operating Cash Flow

₩2.95 Billion
KRW

Capital Expenditures

₩3.19 Billion
KRW

Data as of

Mar 2026
Most recent filing

Yuyu Pharma Inc Capital Reinvestment Ratio (2014–2025)

This chart tracks Yuyu Pharma Inc's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Yuyu Pharma Inc generate cash.

Annual Capital Reinvestment Ratio for Yuyu Pharma Inc (2014–2025)

Year-by-year Capital Reinvestment Ratio for Yuyu Pharma Inc from 2014 to 2025. See free cash flow generation of Yuyu Pharma Inc to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.53x ₩15.88 Billion ₩8.45 Billion ▲ +81.9%
2024 0.29x ₩24.95 Billion ₩7.30 Billion ▼ -97.6%
2023 12.13x ₩420.86 Million ₩5.11 Billion ▲ +800.7%
2021 1.35x ₩4.51 Billion ₩6.07 Billion ▲ +120.5%
2019 0.61x ₩13.19 Billion ₩8.06 Billion ▼ -61.8%
2018 1.60x ₩6.11 Billion ₩9.76 Billion ▼ -82.7%
2017 9.25x ₩561.35 Million ₩5.19 Billion ▲ +3819.4%
2016 0.24x ₩9.82 Billion ₩2.32 Billion ▼ -20.4%
2014 0.30x ₩1.36 Billion ₩404.37 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow